Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: Research
:: Products
:: Services
:: Facilities
:: Contact us
Virchow Products
Biotech R&D

Our dedicated research facility is recognized by Government of India.

Our R&D center has a Doctoral Program (Ph.D) that is registered with Jawarlal Nehru Techonlogoical University, Osmania University, Nagarjuna University and Andhra University.

VBPL also has ongoing collaborative research projects with internationally reputable CSIR labs like Center for Cellular and Molecular Biology, Indian Institute of Chemical Technology, National Institutes of Nutrition and University of Michigan, USA.
Careers

Job search

VBPL job posting system allows candidates to:

  • Search for available jobs
  • Add a resume and apply for a job

College Program

We're looking for students with the talent, aptitude and initiative to get involved with us early in their careers. We will be visiting campuses across the country  to discuss opportunities at our company. Our Scientists are offered the chance to do cutting-edge research in an inspired and resource-rich environment. Research scientists can register for their Ph.D in any of the Institutes like JNTU, Nagarjuna, Osmania or Andhra university.

Benefits

Virchow is recognized as one of the top pharma companies to work for in India. We offer employees one of the most comprehensive benefits package in the industry.

A number of programs reflect Virchow’s unique workplace and provide employees with opportunities to continue their education, and achieve their personal and professional goals. Virchow also offers a wide variety of benefits, services and programs designed to make it easier and more convenient for employees. We also provide convenient transportation to our work place.
 
News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product

 
All Rights Reserved @ Virchow Biotech - Powered By: Effexoft Inc.